Industry Tries To Nix OTC State Regulations
The derivatives industry is lobbying members of Congress to include provisions in the proposed federal derivative laws that would pre-empt any similar state legislation.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: